Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. - Wikidata - wikimedia - TriplyDB

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

http://www.wikidata.org/entity/Q30447031

about

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control Mechanisms of coronavirus cell entry mediated by the viral spike protein Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme Fusion of Enveloped Viruses in Endosomes.Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.Structure, Function, and Evolution of Coronavirus Spike Proteins.Autographa californica multicapsid nucleopolyhedrovirus efficiently infects Sf9 cells and transduces mammalian cells via direct fusion with the plasma membrane at low pH Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells Receptor-independent infection of murine coronavirus: analysis by spinoculation Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain.Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses.Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation.Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.Role of proteases in the release of porcine epidemic diarrhea virus from infected cells.Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.Incorporation of spike and membrane glycoproteins into coronavirus virions.Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride Suppression of coronavirus replication by inhibition of the MEK signaling pathway.Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.Amino acid substitutions in the s2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells.Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection.Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein.Protease-mediated entry via the endosome of human coronavirus 229E.Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

P2860

Q24306622-0C5DE209-28ED-4A10-9370-970BAAAC77BB Q24337838-3C5040E8-28CD-450F-819D-4648098BCEC0 Q24339582-B3E967DC-7A81-44C0-8229-CD787311CEE8 Q26796501-42B7D743-E4D1-46FC-87CD-81A47D6A0884 Q27027678-000441F5-1747-49FA-A651-AA4981EE25D6 Q27487974-1F461A72-3ADC-42FC-A186-67D2306E8C20 Q28073406-8ADD75D4-F4C1-43A5-9F57-E269995D3BB4 Q30301030-F859C7F9-0009-438A-8830-FEC4CB52BFCB Q30354466-B302A12F-CC2C-4713-9327-EDD0F73D606C Q30365699-51FFA5E6-D236-4D8E-8D93-6D582BA207D3 Q30432156-88EB1686-A034-4062-9874-8DEA7BF6878F Q30436297-03A947F5-891F-4536-9837-43212B548E5C Q30439990-F5F0C005-8FA0-414C-B84A-4844E3D50072 Q33516234-88151D59-9D3D-48E5-81F4-4257599CEA83 Q33760875-78B35265-59C3-4807-9AA5-9112B3022423 Q33826852-10CC1DE5-B754-45BA-A76C-33C091826CCA Q34003783-93C8BA70-C7AC-41E3-B99B-D6186C93657A Q34015988-9DE405C2-CE81-4EC8-9EEF-D525F11C9C21 Q34193942-75AE87DB-C292-4105-8352-6A58BE726B4B Q34545634-E615E194-3A1D-4862-B6E8-A1E8C57B47F7 Q34647808-B1C86D17-B71F-4C43-99E5-862DDB558E0B Q34717693-5A803D51-D7DB-463B-BA77-247D27C358BE Q34983662-F891B1CD-FB83-4C04-AEE1-9A81DED37488 Q35009468-7095C657-EDC0-43F3-B7FE-FE197204EE37 Q35076795-69A5D291-F12A-48EF-B0AD-F5BA5A5B2C69 Q35140298-2B68F147-B17E-4C4F-9A60-4AE54D7600BD Q35399141-666C12DC-05CD-4AFA-ABFB-85CD164F4C34 Q35544383-CF6A4013-2CDD-41D2-BF01-10FBFE10EDD2 Q35613695-DB6CAF1E-FC85-4230-9839-882F4CFB1220 Q35634933-395ABF6C-4161-4294-857D-0FA3E61911DE Q35735214-830F58DE-AF54-4346-BB90-5698313DDEE6 Q35943657-0120AA97-3D47-424D-BFC1-E46A82AA8359 Q36086649-58484386-583D-4CB7-BD25-1E32ABD74E88 Q36099072-4FE00CB7-16D4-42D0-A84A-09CFD5E16583 Q36424025-9359BC7E-4806-4C82-A740-85DE1DD2F496 Q36447896-CCA20F48-6BDD-4607-9315-6C07B3E4950D Q36520754-D5D17EDB-5CA1-448C-94EF-A84A4FDD8D5F Q36974675-3BD6B925-0527-4064-A278-E100DFEF4D45 Q37033358-1711EDE5-A710-4450-B073-C9E03C9E8071 Q37138587-BE379F06-B7BF-4CDC-A806-94B488913106

P2860

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

http://www.wikidata.org/entity/Q30447031

description

2005 nî lūn-bûn

@nan

2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@ast

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@en

type

label

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@ast

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@en

prefLabel

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@ast

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@en

P1433

Q30447031-2886EF68-EEDB-4A5A-9B23-D1CCCA0A33A6

P1476

Q30447031-BF3A4138-829A-4118-B73E-8ADA91DA13CA

P2093

Q30447031-02E85060-2646-4A7E-A358-AD32C108F758

Q30447031-10D67035-706E-4605-A939-3E7B7C53CF66

Q30447031-BEBD73FC-D7D0-45D3-A314-C0327FC5F91F

Q30447031-EF274950-7CD8-49B4-942E-896F17CBA3AE

P2860

Q30447031-0399ACDD-540D-4278-9692-C0D98D1587B7

Q30447031-133B2975-1047-4B21-A80F-739523869080

Q30447031-1F15D8C7-C25A-40FA-883D-793ABBEA4829

Q30447031-24F40FE9-41C6-4DB2-B0AA-0B2933328F2C

Q30447031-267FD79E-F5B6-4F89-A0D1-2DC8E65ABFFE

Q30447031-2766BFC6-40D7-4ED2-8211-ED8EE11A5476

Q30447031-38CAB8A0-30FD-4658-B1C3-FC5166C4A30B

Q30447031-3A9CECF2-E12E-4440-BC4F-191D768EC3C8

Q30447031-41E8BC4F-719B-4DA7-A168-CF057E5CA0BF

Q30447031-55B27D75-4237-49A9-B83A-08D16750C3B7

P304

Q30447031-E0C6FBC5-30A7-428E-904E-0FE704B30CDD

P31

Q30447031-77599B54-9779-4B4A-B961-BA2EA90403BC

P356

Q30447031-129ED10C-D0AD-4B38-A229-F3DBF24F86EC

P407

Q30447031-9E4DE963-6B8A-4F02-9971-ABD1E19BFEB2

P433

Q30447031-F490F8F8-2497-401D-8BAF-4E670AF25B7C

P478

Q30447031-0F0A9A77-8820-427B-AF9B-D58C9775293B

P50

Q30447031-8534AE96-9C63-45B8-80CA-DCCB79FB1BB0

P577

Q30447031-2B0D1A51-1FE1-4C92-9D8A-96650F80D586

P5875

Q30447031-88279BAC-929B-4A53-8C26-4D26E56376BE

P698

Q30447031-2DDACE10-341F-4280-B506-29FA13F76C07

P932

Q30447031-3A759E92-4A88-4F29-9CD3-EC51C38BFFA5

P356

PNAS.0503203102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection.

@en

P2093

Fumihiro Taguchi

http://www.w3.org/2001/XMLSchema#string

Makoto Ujike

http://www.w3.org/2001/XMLSchema#string

Masato Tashiro

http://www.w3.org/2001/XMLSchema#string

Shutoku Matsuyama

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

The role of neutrophil elastase in acute lung injury

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

A novel coronavirus associated with severe acute respiratory syndrome

The Genome sequence of the SARS-associated coronavirus

Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).

Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein.

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry

Activation of influenza A viruses by trypsin treatment.

P304

12543-12547

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0503203102

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Shigeru Morikawa

P577

2005-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7644854

http://www.w3.org/2001/XMLSchema#string

P698

16116101

http://www.w3.org/2001/XMLSchema#string

P932

1194915

http://www.w3.org/2001/XMLSchema#string